HCA(HCA)
HCA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $78.50B | $81.58B | $85.48B | $91.45B | $96.86B |
| Low | $77.83B | $79.97B | $82.97B | $89.70B | $95.00B |
| High | $79.01B | $82.62B | $87.59B | $92.74B | $98.22B |
| EBITDA Avg | $16.68B | $17.33B | $18.16B | $19.43B | $20.58B |
| Low | $16.53B | $16.99B | $17.63B | $19.06B | $20.18B |
| High | $16.79B | $17.55B | $18.61B | $19.70B | $20.87B |
| EBIT Avg | $12.93B | $13.44B | $14.08B | $15.06B | $15.95B |
| Low | $12.82B | $13.17B | $13.67B | $14.77B | $15.65B |
| High | $13.01B | $13.61B | $14.43B | $15.27B | $16.18B |
| Net Income Avg | $6.82B | $7.44B | $8.23B | $9.05B | $10.34B |
| Low | $6.67B | $7.11B | $7.59B | $8.83B | $10.08B |
| High | $6.97B | $7.77B | $8.87B | $9.22B | $10.53B |
| EPS Avg | $29.57 | $32.23 | $35.45 | $39.24 | $44.81 |
| Low | $28.91 | $30.82 | $32.89 | $38.26 | $43.69 |
| High | $30.22 | $33.68 | $38.44 | $39.96 | $45.63 |
| Analysts (Rev / EPS) | 18 / 14 | 18 / 15 | 16 / 11 | 14 / 4 | 14 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $19.40B | $19.87B | $19.89B | $20.66B | $20.24B | $20.75B | $20.63B | $21.61B |
| Low | $18.95B | $19.50B | $19.35B | $20.10B | $19.69B | $20.19B | $20.07B | $21.03B |
| High | $19.81B | $20.26B | $20.35B | $21.13B | $20.70B | $21.22B | $21.10B | $22.10B |
| EBITDA Avg | $4.12B | $4.22B | $4.23B | $4.39B | $4.30B | $4.41B | $4.38B | $4.59B |
| Low | $4.03B | $4.14B | $4.11B | $4.27B | $4.18B | $4.29B | $4.26B | $4.47B |
| High | $4.21B | $4.30B | $4.32B | $4.49B | $4.40B | $4.51B | $4.48B | $4.70B |
| EBIT Avg | $3.19B | $3.27B | $3.28B | $3.40B | $3.33B | $3.42B | $3.40B | $3.56B |
| Low | $3.12B | $3.21B | $3.19B | $3.31B | $3.24B | $3.32B | $3.31B | $3.46B |
| High | $3.26B | $3.34B | $3.35B | $3.48B | $3.41B | $3.50B | $3.48B | $3.64B |
| Net Income Avg | $1.51B | $1.78B | $1.73B | $1.80B | $1.68B | $2.03B | $1.78B | $1.89B |
| Low | $1.43B | $1.68B | $1.67B | $1.74B | $1.62B | $1.96B | $1.72B | $1.82B |
| High | $1.60B | $1.86B | $1.78B | $1.86B | $1.73B | $2.09B | $1.83B | $1.94B |
| EPS Avg | $6.78 | $7.99 | $7.77 | $8.10 | $7.53 | $9.09 | $7.99 | $8.47 |
| Low | $6.42 | $7.53 | $7.49 | $7.81 | $7.27 | $8.78 | $7.71 | $8.18 |
| High | $7.17 | $8.34 | $8.00 | $8.34 | $7.75 | $9.36 | $8.23 | $8.72 |
| Analysts (Rev / EPS) | 14 / 13 | 14 / 13 | 9 / 5 | 7 / 5 | 7 / 5 | 13 / 5 | 12 / 6 | 6 / 6 |